Immunoprecise Antibodies (IPA) Peer Comparison
$1.77
As on 02-Oct-2025 09:30EDT
Market cap
$96 Mln
Revenue (TTM)
$25 Mln
P/E Ratio
--
P/B Ratio
5.6
Div. Yield
0 %
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
96 | 330 | 417 | 237 | 151 |
Revenue (CA$ Mln) |
25 | 928 | 321 | 290 | 309 |
Net Profit (CA$ Mln) |
-30.23 | -21.69 | -259.27 | -110.73 | 86.61 |
Net Margin (%) |
-123.30 | -2.34 | -80.67 | -38.15 | 28.02 |
RoE (%) |
-105.08 | -2.00 | -29.99 | -21.70 | 18.71 |
Price to Earnings |
-- | -- | -- | -- | 2.44 |
Price-To-Book |
5.61 | 0.43 | 0.79 | 0.62 | 0.44 |
Cashflow (CA$ Mln)
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-6.41 | 70.92 | -165.75 | 16.01 | -7.59 |
|
Cash Flow from Investing Activities
|
-0.80 | 17.45 | -47.79 | -14.33 | -81.07 |
|
Cash from Financing Activities
|
14.89 | -54.49 | 148.66 | -0.12 | 39.33 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-71.45 | -1.23 | -59.69 | 0.24 | -5.32 |
|
ROE (%)
|
-105.08 | -1.41 | -121.13 | 0.28 | -5.43 |
|
ROA (%)
|
-57.90 | -1.17 | -53.93 | 0.19 | -3.67 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-123.30 | -1.67 | -222.35 | 0.46 | -9.55 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.00 | 0.03 | -0.09 | 0.27 | 0.16 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-11.25 | 83.36 | 9.00 | 102.29 | 60.88 |
|
EPS Growth (%)
|
-- | 0.83 | 0.24 | 1.02 | 0.80 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -27.71 | -0.16 | 153.84 | -15.32 |
|
Price / Book Value
|
-- | 0.40 | 0.20 | 0.43 | 0.78 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-0.09 | 6.96 | -0.66 | 3.19 | -17.08 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.57 | 0.15 | 0.72 | 0.18 | 0.03 |
|
Short term debt to equity ratio
|
0.08 | 0.03 | 0.04 | 0.05 | 0.00 |
|
Current Ratio
|
2.08 | 4.88 | 3.12 | 4.31 | 2.26 |
|
Quick Ratio
|
1.85 | 3.47 | 2.10 | 2.16 | 1.28 |
|
Interest Coverage
|
-115.95 | -1.10 | -7.01 | 3.42 | -- |
Operating Efficiency Ratios
| Immunoprecise Antibodies (IPA) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | Aurora Cannabis (ACB) | Organigram Holdings (OGI) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.60 | 3.22 | 19.62 | 12.30 | 34.85 |
|
Asset Turnover
|
0.47 | 0.70 | 0.24 | 0.41 | 0.38 |
|
Receivable days
|
66.09 | 11.30 | 71.03 | 46.66 | 100.11 |
|
Inventory Days
|
70.47 | 68.84 | 167.38 | 497.86 | 210.35 |
|
Payable days
|
155.71 | 14.63 | 52.79 | 56.10 | 138.90 |
|
Cash Conversion Cycle
|
-19.15 | 65.51 | 185.62 | 488.43 | 171.56 |